Treatment Options in Advanced mCSPC

Insights from 2024 ASCO® GU Annual Meeting
F

ASCO® GU 2024 Insights: "Prognostic Value of FDG, PSMA, and DOTATATE Uptake on PET Imaging in mCRPC"

By Insights from 2024 ASCO® GU Annual Meeting FEATURING Frédéric Pouliot
By Insights from 2024 ASCO® GU Annual Meeting FEATURING Frédéric Pouliot
95 views
February 13, 2024
Comments 0
Login to view comments. Click here to Login
18:59

Management of Toxicities Associated With ARSi+ADT Therapy in mCSPC

Jochen Walz

174 views
09:59

ASCO® GU 2024 Insights: "PROMPT-2 Trial - PSA Response Among Patient…

Insights from 2024 ASCO® GU Annual Meeting

G. Brown

211 views
17:26

Local Treatment of the Prostate in Synchronous mHSPC

PROSCA & BLADDR 2023

A. Bossi

162 views
15:59

PSA Attainment & Reduction in Frontline mHSPC

Moffitt Cancer Center

J. Chadha

142 views
21:17

Time to Castrate Resistance in mCSPC Using Standard of Care Intensif…

Manish Kohli

545 views
03:49

ESMO 2023 Insights: "Effect of Rapid Ultra-Low Prostate-Specific Ant…

Insights from 2023 ESMO Annual Meeting

A. Merseburger

459 views
18:42

Theragnostics in Metastatic Prostate Cancer: Diagnosis and Treatment

International Urology Cancer Summit - IUCS

G. Gnanasegaran

249 views
23:23

New Imaging Technology in Prostate Cancer

Fox Chase Cancer Center

J. Yu

430 views